Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro.
暂无分享,去创建一个
Tracey Hurrell | A. Ellero | A. Cromarty | Tracey Hurrell | Andrea Antonio Ellero | Zelie Flavienne Masso | Allan Duncan Cromarty
[1] S. Fey,et al. Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[2] Terry S Peters,et al. Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? , 2005, Toxicologic pathology.
[3] Christopher S. Chen,et al. Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.
[4] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[5] Bruno Sarmento,et al. An evaluation of the latest in vitro tools for drug metabolism studies , 2014, Expert opinion on drug metabolism & toxicology.
[6] Leming Shi,et al. Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes , 2011, Drug Metabolism And Disposition.
[7] W. M. Lee,et al. Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.
[8] F. Pampaloni,et al. The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.
[9] G. Darlington,et al. Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2 , 1989, In Vitro Cellular & Developmental Biology.
[10] Jyrki Lötjönen,et al. A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses , 2010, PloS one.
[11] S. Takayama,et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[12] F. Noor,et al. Organotypic Cultures of Hepg2 Cells for In Vitro Toxicity Studies , 2011 .
[13] Genee Y. Lee,et al. The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.
[14] JONG BIN Kim,et al. Three-dimensional tissue culture models in cancer biology. , 2005, Seminars in cancer biology.
[15] José Vicente Castell,et al. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo. , 2007, Chemico-biological interactions.
[16] A. Ivascu,et al. Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.
[17] R. Andrade,et al. Drug-induced hepatotoxicity , 2003, The New England journal of medicine.
[18] C. Selden,et al. What keeps hepatocytes on the straight and narrow? Maintaining differentiated function in the liver , 1999, Gut.
[19] Jung-Woog Shin,et al. Potential of engineering methodologies for the application to pharmaceutical research , 2012, Archives of pharmacal research.
[20] L. Kunz-Schughart,et al. Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.
[21] J. M. Ryan,et al. The influence of culture medium volume on cell density and lifespan of human diploid fibroblasts. , 1975, Experimental cell research.
[22] S. Fey,et al. The Cultural Divide: Exponential Growth in Classical 2D and Metabolic Equilibrium in 3D Environments , 2014, PloS one.
[23] Hwan-You Chang,et al. Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin , 2006, Cell and Tissue Research.
[24] A. Ivascu,et al. Diversity of cell-mediated adhesions in breast cancer spheroids. , 2007, International journal of oncology.
[25] S. Duncan,et al. Protocol for directed differentiation of human pluripotent stem cells toward a hepatocyte fate , 2014 .